BMY
BMY
NYSE · Pharmaceuticals

Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$64.72
+0.57 (+0.89%)
As of Aug 8, 1:01 AM ET ·
Analyst Consensus
Hold
35
Analysts
Very High
Coverage
Buy 14 40%
Hold 19 54%
Sell 2 6%
Price Target
Analyst Price Target +169.6% upside
Low Target $130.78
Average Target $174.50
High Target $195.10
Current Price $64.72
Current
$64.72
Target
$174.50
$130.78 $174.50 avg $195.10
Scenario Analysis
Bear Case
$130.78
102.1%
Low target
Base Case
$174.50
+169.6%
Avg target
Bull Case
$195.10
+201.5%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$68.10
-5.0% from high
52-Week Low
$42.52
+52.2% from low
50-Day SMA
$55.66
+16.3% vs SMA
200-Day SMA
$49.00
+32.1% vs SMA
RSI (14)
74.1
Overbought
Target vs 52W High
$174.50
+156.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
 Sell 44 52% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
 Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
 Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
 Hold 24 54% $209.87 +188.8%